Premier Biomedical Inc Stock Price - BIEI

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Premier Biomedical (QB) BIEI Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.0004 +3.96% 0.0105 0.0108 0.01 0.0107 0.0101 15:56:24
Bid Price Ask Price Spread Spread % News
0.0105 0.0108 0.0003 2.78% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
41 1,265,599 $ 0.0103 $ 13.09k 2.51M 0.0030 - 0.03
Last Trade Time Type Quantity Stock Price Currency
15:56:24 4,000 $0.01 USD

Premier Biomedical (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 5.16M 491.85M $ -1.77M - -2.92 403.77M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
53.38k 0.01% $ - 0.00% - -

more financials information »

Premier Biomedical (QB) News

Latest BIEI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BIEI Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.01080.01250.00950.0000391k2M1M-0.0003-2.78%
1 Month0.00730.01460.0067090.0000391k9M3M0.003243.84%
3 Months0.01090.01520.00650.0000391k9M2M-0.0004-3.67%
6 Months0.0080.02450.00430.0000391k46M7M0.002531.25%
1 Year0.0140.02550.0029830.0000248k63M6M-0.0035-25.00%
3 Years0.260.30.00230.0000063M3M-0.2495-95.96%
5 Years0.350.550.00230.0000063M3M-0.3395-97.00%

Premier Biomedical (QB) Description

Premier Biomedical, Inc. has acquired exclusive licenses for patented and patent-pending medications/medical procedures to develop cures for a significant number of the most debilitating and often fatal illnesses affecting mankind: Amyotrophic Lateral Sclerosis (ALS), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Clinical Depression, Alzheimer's Disease, Blood Sepsis, Atherosclerosis and Cancer. In addition, in September of 2016, they formed a joint venture to develop manufacture, market and sell an initially small, but expanding line of all-natural, opioid-free pain relief products, including skin patches, roll-ons, creams, sprays, etc. They have a management team with extensive experience and contacts in the medical/pharmaceutical/pain management fields as well as a demonstrated track record of launching new business ventures in a competitive environment. Their extensive contacts in the medical/pharmaceutical/pain management industries will ensure that new developments will achieve maximum visibility and exposure to the market. Transparency and accountability will continue to be ensured via regular issuance of technical progress reports, financials, and investor relations reports to maintain investor enthusiasm.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.